Free Newsletter
FDA warns Asians of epilepsy med risks
Free newsletter via e-mail
Tools
Treatment with certain epilepsy drugs--such as Pfizer's Dilantin, Bertek Pharmaceuticals' Phenytek and Eisai's Cerebyx--may expose some Asian patients to serious skin reactions, the FDA warned Monday. Report
More stories about FDA warning
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: